Latest Period
Q4 2025
Security Snapshot
InspireMD, Inc. - Common Stock, $0.0001 par value per share (NSPR) Institutional Ownership
CUSIP: 45779A846
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
44
Shares (Excl. Options)
23,169,255
Price
$1.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- NSPR on Nasdaq
- Shares outstanding
- 49,358,301
- Price per share
- $1.34
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 23,169,255
- Total reported value
- $41,235,253
- % of total 13F portfolios
- 0%
- Share change
- +439,020
- Value change
- -$50,631
- Number of holders
- 44
- Price from insider filings
- $1.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 45779A846.
- 44 institutions reported positions in Q4 2025.
- 11 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 44 to 10 between Q4 2025 and Q1 2026.
- Reported value moved from $41,235,253 to $5,775,094.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 44 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 45779A846?
CUSIP 45779A846 identifies NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45779A846:
Significant Owners of InspireMD, Inc. - Common Stock, $0.0001 par value per share (NSPR) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 10% | $67,729,915 | 28,103,699 | MARSHALL WACE, LLP | 30 Sep 2025 | |||
| Rosalind Advisors, Inc. | 9.2% | -2.2% | $19,557,045 | 10,987,104 | 0% | Rosalind Advisors, Inc. | 31 Dec 2025 | |
| Nantahala Capital Management, LLC | 10% | 0% | $10,256,307 | +$2,934,884 | 4,255,729 | +40% | Nantahala Capital Management, LLC | 30 Sep 2025 |
| Lawless Michael A | 8.6% | $8,711,502 | 3,614,731 | Michael A. Lawless | 26 Jun 2025 | |||
| Aberdeen Group plc | 7.5% | +26% | $5,648,588 | +$1,232,200 | 3,173,364 | +28% | Aberdeen Group plc | 31 Dec 2025 |
| ORBIMED ADVISORS LLC | 7.4% | +82% | $5,577,461 | +$1,780,000 | 3,133,405 | +47% | ORBIMED ADVISORS LLC | 31 Dec 2025 |
| Slosman Marvin | 5.2% | $4,167,519 | 2,556,760 | Marvin Slosman | 22 Jan 2026 | |||
| Parkman Healthcare Partners LLC | 5.8% | $5,881,926 | 2,440,633 | Parkman Healthcare Partners LLC | 30 Sep 2025 | |||
| Nantahala Capital Partners Limited Partnership | 5.7% | $5,827,419 | 2,418,016 | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 30 Sep 2025 | |||
| Velan Capital Investment Management LP | 5.1% | $5,059,127 | 2,143,698 | Velan Capital Master Fund LP | 30 Jul 2025 | |||
| Shore Craig | 3.5% | $3,577,657 | 1,484,505 | Craig Shore | 26 Jun 2025 |
As of 31 Dec 2025, 44 institutional investors reported holding 23,169,255 shares of InspireMD, Inc. - Common Stock, $0.0001 par value per share (NSPR). This represents 47% of the company’s total 49,358,301 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of InspireMD, Inc. - Common Stock, $0.0001 par value per share (NSPR) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 7.9% | 3,905,743 | 0% | 2.7% | $6,952,222 |
| Nantahala Capital Management, LLC | 6.8% | 3,376,484 | 0% | 0.36% | $6,010,142 |
| Aberdeen Group plc | 6.4% | 3,173,364 | +28% | 0.01% | $5,648,588 |
| ORBIMED ADVISORS LLC | 6.3% | 3,133,405 | +47% | 0.12% | $5,577,461 |
| Parkman Healthcare Partners LLC | 4.9% | 2,416,518 | -0.99% | 0.41% | $4,301,402 |
| Velan Capital Investment Management LP | 4.3% | 2,143,698 | 0% | 2.2% | $3,815,782 |
| MARSHALL WACE, LLP | 3.8% | 1,860,405 | 0% | 0% | $3,311,521 |
| Soleus Capital Management, L.P. | 2.3% | 1,150,000 | -22% | 0.09% | $2,047,000 |
| PURA VIDA INVESTMENTS, LLC | 0.91% | 450,517 | 0% | 3% | $801,920 |
| INGALLS & SNYDER LLC | 0.78% | 384,300 | +71% | 0.03% | $684,000 |
| Affiance Financial, LLC | 0.51% | 250,370 | 0% | 0.07% | $445,659 |
| CITADEL ADVISORS LLC | 0.39% | 193,710 | +410% | 0% | $344,804 |
| MILLENNIUM MANAGEMENT LLC | 0.25% | 124,090 | -16% | 0% | $220,880 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.23% | 114,085 | 0.03% | $203,071 | |
| BlackRock, Inc. | 0.12% | 60,895 | +13% | 0% | $108,393 |
| COURIER CAPITAL LLC | 0.11% | 55,000 | 0% | 0.01% | $97,900 |
| VESTIA PERSONAL WEALTH ADVISORS | 0.09% | 42,425 | 0% | 0.04% | $68,728 |
| MORGAN STANLEY | 0.08% | 41,833 | -51% | 0% | $74,463 |
| NORTHERN TRUST CORP | 0.07% | 33,572 | 0% | 0% | $59,758 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.07% | 32,550 | 0% | 0% | $57,940 |
| Legato Capital Management LLC | 0.05% | 26,850 | 0% | $47,793 | |
| Schonfeld Strategic Advisors LLC | 0.05% | 23,334 | -73% | 0% | $41,532 |
| Creative Planning | 0.04% | 19,714 | +0.74% | 0% | $35,091 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.04% | 18,244 | 0% | 0% | $32,474 |
| Virtu Financial LLC | 0.04% | 17,684 | 0% | $31,000 |
Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value per share (NSPR) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,543,040 | $5,775,094 | -$74,806 | $1.63 | 10 |
| 2025 Q4 | 23,169,255 | $41,235,253 | -$50,631 | $1.78 | 44 |
| 2025 Q3 | 22,730,210 | $54,778,990 | +$20,913,736 | $2.41 | 40 |
| 2025 Q2 | 14,061,920 | $31,922,818 | +$2,512,314 | $2.27 | 36 |
| 2025 Q1 | 12,917,013 | $34,746,467 | +$554,615 | $2.69 | 34 |
| 2024 Q4 | 12,710,904 | $33,407,511 | +$811,860 | $2.63 | 29 |
| 2024 Q3 | 12,402,374 | $33,215,449 | +$1,209,473 | $2.68 | 27 |
| 2024 Q2 | 11,951,922 | $29,859,952 | +$4,430,429 | $2.50 | 23 |
| 2024 Q1 | 10,178,288 | $23,962,111 | -$399,400 | $2.37 | 25 |
| 2023 Q4 | 10,339,444 | $29,052,785 | +$1,719,804 | $2.81 | 27 |
| 2023 Q3 | 8,762,240 | $28,676,783 | +$2,327,230 | $3.27 | 25 |
| 2023 Q2 | 8,054,251 | $20,221,241 | +$20,007,582 | $2.51 | 22 |
| 2023 Q1 | 88,752 | $103,127 | -$54,760 | $1.12 | 12 |
| 2022 Q4 | 155,809 | $137,173 | +$21,576 | $0.86 | 14 |
| 2022 Q3 | 112,334 | $168,630 | -$78,516 | $1.50 | 11 |
| 2022 Q2 | 129,060 | $256,202 | -$10,358 | $1.99 | 10 |
| 2022 Q1 | 140,275 | $455,524 | -$96,895 | $3.21 | 13 |
| 2021 Q4 | 172,505 | $527,325 | -$27,335 | $3.02 | 15 |
| 2021 Q3 | 170,103 | $703,514 | -$1,360,154 | $4.10 | 12 |
| 2021 Q2 | 450,832 | $2,277,560 | +$2,277,560 | $5.05 | 14 |